Paradoxical role of angiotensin II type 2 receptors in resistance arteries of old rats

Hypertension

Volumn 50, Issue 1, 2007, Pages 96-102

  Pinaud, Frederic ^c   Bocquet, Arnaud ^a,b   Dumont, Odile ^a,b   Retailleau, Kevin ^a,b   Baufreton, Christophe ^c   Andriantsitohaina, Ramaroson ^a,b   Loufrani, Laurent ^a,b   Henrion, Daniel ^a,b,d  

^a CNRS   (France)

^b UNIVERSITÉ D'ANGERS   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d Universite d'Angers   (France)

Author keywords

Aging; Angiotensin II receptors; Endothelium; Microcirculation; NO; Oxidative stress; Vasodilator agents

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDRALAZINE; REACTIVE OXYGEN METABOLITE; TEMPOL; WATER;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTERY ENDOTHELIUM; ARTERY MUSCLE; ARTERY RESISTANCE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; ISOLATED ARTERY; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RISK FACTOR; SMOOTH MUSCLE CONTRACTION; STATISTICAL ANALYSIS; TREATMENT DURATION; WESTERN BLOTTING;

AGING; ANIMALS; ENDOTHELIAL CELLS; HYDRALAZINE; MALE; MESENTERIC ARTERIES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RECEPTOR, ANGIOTENSIN, TYPE 2; REGIONAL BLOOD FLOW; TISSUE DISTRIBUTION; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATION; VASODILATOR AGENTS;

EID: 34250796304     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.106.085035     Document Type: Article

References (37)

1. Segal SS. Regulation of blood flow in the microcirculation. Microcirculation. 2005;12:33-45.
2. You D, Loufrani L, Baron C, Levy BI, Widdop RE, Henrion D. High blood pressure reduction reverses angiotensin ii type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive rats. Circulation. 2005;111:1006-1011.
3. Brandes RP, Fleming I, Busse R. Endothelial aging. Cardiovasc Res. 2005;66:286-294.
4. Barton M. Ageing as a determinant of renal and vascular disease: Role of endothelial factors. Nephrol Dial Transplant. 2005;20:485-490.
5. Marin J, Rodriguez-Martinez MA. Age-related changes in vascular responses. Exp Gerontol. 1999;34:503-512.
6. Safar ME. Systolic hypertension in the elderly: arterial wall mechanical properties and the renin-angiotensin-aldosterone system. J Hypertens. 2005;23:673-681.
7. Irion GL, Vasthare US, Tuma RF. Age-related change in skeletal muscle blood flow in the rat. J Gerontol. 1987;42:660-665.
8. Lawrenson L, Poole JG, Kim J, Brown C, Patel P, Richardson RS. Vascular and metabolic response to isolated small muscle mass exercise: Effect of age. Am J Physiol Heart Circ Physiol. 2003;285:H1023-H1031.
9. Vanhoutte PM, Feletou M, Taddei S. Endothelium-dependent contractions in hypertension. Br J Pharmacol. 2005;144:449-458.
10. Allen JD, Wilson JB, Tulley RT, Lefevre M, Welsch MA. Influence of age and normal plasma fibrinogen levels on flow-mediated dilation in healthy adults. Am J Cardiol. 2000;86:703-705, A709.
11. Rajagopalan S, Brook R, Mehta RH, Supiano M, Pitt B. Effect of losartan in aging-related endothelial impairment. Am J Cardiol. 2002;89:562-566.
12. Saka B, Oflaz H, Erten N, Bahat G, Dursun M, Pamukcu B, Mercanoglu F, Meric M, Karan MA. Non-invasive evaluation of endothelial function in hypertensive elderly patients. Arch Gerontol Geriatr. 2005;40:61-71.
13. Matrougui K, Loufrani L, Heymes C, Levy BI, Henrion D. Activation of at(2) receptors by endogenous angiotensin ii is involved in flow-induced dilation in rat resistance arteries. Hypertension. 1999;34:659-665.
14. Matrougui K, Levy BI, Henrion D. Tissue angiotensin ii and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats. Br J Pharmacol. 2000;130:521-526.
15. Gorny D, Loufrani L, Kubis N, Levy BI, Henrion D. Chronic hydralazine improves flow (shear stress)-induced endothelium-dependent dilation in mouse mesenteric resistance arteries in vitro. Microvasc Res. 2002;64:127-134.
16. Bagi Z, Toth E, Koller A, Kaley G. Microvascular dysfunction after transient high glucose is caused by superoxide-dependent reduction in the bioavailability of no and bh(4). Am J Physiol Heart Circ Physiol. 2004;287:H626-H633.
17. Gros R, Van Wert R, You X, Thorin E, Husain M. Effects of age, gender, and blood pressure on myogenic responses of mesenteric arteries from c57bl/6 mice. Am J Physiol Heart Circ Physiol. 2002;282:H380-H388.
18. Shipley RD, Muller-Delp JM. Aging decreases vasoconstrictor responses of coronary resistance arterioles through endothelium-dependent mechanisms. Cardiovasc Res. 2005;66:374-383.
19. Luscher TF, Dohi Y, Tschudi M. Endothelium-dependent regulation of resistance arteries: alterations with aging and hypertension. J Cardiovasc Pharmacol. 1992;19:S34-S42.
20. Woodman CR, Price EM, Laughlin MH. Selected contribution: aging impairs nitric oxide and prostacyclin mediation of endothelium-dependent dilation in soleus feed arteries. J Appl Physiol. 2003;95:2164-2170.
21. Spier SA, Delp MD, Meininger CJ, Donato AJ, Ramsey MW, Muller-Delp JM. Effects of ageing and exercise training on endothelium-dependent vasodilatation and structure of rat skeletal muscle arterioles. J Physiol. 2004;556:947-958.
22. Smith AR, Hagen TM. Vascular endothelial dysfunction in aging: Loss of akt-dependent endothelial nitric oxide synthase phosphorylation and partial restoration by (r)-alpha-lipoic acid. Biochem Soc Trans. 2003;31:1447-1449.
23. Henrion D, Kubis N, Levy BI. Physiological and pathophysiological functions of the at(2) subtype receptor of angiotensin II: from large arteries to the microcirculation. Hypertension. 2001;38:1150-1157.
24. Levy BI. Can angiotensin II type 2 receptors have deleterious effects in cardiovascular disease? Implications for therapeutic blockade of the renin-angiotensin system. Circulation. 2004;109:8-13.
25. Widdop RE, Jones ES, Hannan RE, Gaspari TA. Angiotensin at2 receptors: cardiovascular hope or hype? Br J Pharmacol. 2003;140:809-824.
26. Widdop RE, Matrougui K, Levy BI, Henrion D. At2 receptor-mediated relaxation is preserved after long-term at1 receptor blockade. Hypertension. 2002;40:516-520.
27. Soares de Moura R, Resende AC, Emiliano AF, Tano T, Mendes-Ribeiro AC, Correia ML, de Carvalho LC. The role of bradykinin, at2 and angiotensin 1-7 receptors in the edrf-dependent vasodilator effect of angiotensin ii on the isolated mesenteric vascular bed of the rat. Br J Pharmacol. 2004;141:860-866.
28. Siragy HM, Jaffa AA, Margolius HS, Carey RM. Renin-angiotensin system modulates renal bradykinin production. Am J Physiol. 1996;271:R1090- R1095.
29. Abadir PM, Periasamy A, Carey RM, Siragy HM. Angiotensin II type 2 receptor-bradykinin b2 receptor functional heterodimerization. Hypertension. 2006;48:316-322.
30. Bergaya S, Hilgers RH, Meneton P, Dong Y, Bloch-Faure M, Inagami T, Alhenc-Gelas F, Levy BI, Boulanger CM. Flow-dependent dilation mediated by endogenous kinins requires angiotensin at2 receptors. Circ Res. 2004;94:1623-1629.
31. Savoia C, Tabet F, Yao G, Schiffrin EL, Touyz RM. Negative regulation of rhoa/rho kinase by angiotensin ii type 2 receptor in vascular smooth muscle cells: role in angiotensin ii-induced vasodilation in stroke-prone spontaneously hypertensive rats. J Hypertens. 2005;23:1037-1045.
32. Touyz RM. Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathophysiology. Antioxid Redox Signal. 2005;7:1302-1314.
33. Droge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002;82:47-95.
34. Daiber A, Mulsch A, Hink U, Mollnau H, Warnholtz A, Oelze M, Munzel T. The oxidative stress concept of nitrate tolerance and the antioxidant properties of hydralazine. Am J Cardiol. 2005;96:25i-36i.
35. Bagi Z, Koller A, Kaley G. Superoxide-NO interaction decreases flow-and agonist-induced dilations of coronary arterioles in type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol. 2003;285:H1404-H1410.
36. Najjar SS, Scuteri A, Lakatta EG. Arterial aging: is it an immutable cardiovascular risk factor? Hypertension. 2005;46:454-462.
37. Sun D, Huang A, Koller A, Kaley G. Decreased arteriolar sensitivity to shear stress in adult rats is reversed by chronic exercise activity. Microcirculation. 2002;9:91-97.